Literature DB >> 9010304

Herpes simplex virus type 2 synergizes with interferon-gamma in the induction of nitric oxide production in mouse macrophages through autocrine secretion of tumour necrosis factor-alpha.

H Baskin1, S Ellermann-Eriksen, J Lovmand, S C Mogensen.   

Abstract

We have analysed the ability of herpes simplex virus type 2 (HSV-2) to induce nitric oxide (NO) production in resting BALB/c mouse peritoneal macrophages. In most experiments, macrophages produced very small amounts of NO upon infection with HSV-2. Mock virus preparations did not induce NO production, and virus inactivation experiments showed that infectious virus was required. Since interferon-gamma (IFN-gamma) is the prototype cytokine that is able to induce significant NO production in macrophages, we found it of interest to examine the influence of HSV-2 infection on the IFN-gamma-induced NO production. The virus exerted a synergistic effect on the IFN-gamma-induced NO release, which was accompanied by induction of the iNOS-gene as revealed by RT-PCR. This effect was largely dependent on the presence of infectious virus particles, since only a minor effect was seen with mock virus and inactivated virus preparations. From experiments with neutralizing antibodies to tumour necrosis factor-alpha (TNF-alpha) and IFN-alpha/beta it was concluded that the synergistic effect is dependent on autocrine secretion of TNF-alpha, which acts as a second signal and synergizes with IFN-gamma in NO production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9010304     DOI: 10.1099/0022-1317-78-1-195

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Nitric oxide and macrophage antiviral extrinsic activity.

Authors:  F Benencia; M C Courreges
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

2.  Virus-cell interactions regulating induction of tumor necrosis factor alpha production in macrophages infected with herpes simplex virus.

Authors:  S R Paludan; S C Mogensen
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

3.  Tumor necrosis factor alpha and macrophages in the brain of herpes simplex virus type 1-infected BALB/c mice.

Authors:  Mark Fields; Mei Zheng; Ming Zhang; Sally S Atherton
Journal:  J Neurovirol       Date:  2006-12       Impact factor: 2.643

4.  Dysregulated expression of IFN-gamma and IL-10 and impaired IFN-gamma-mediated responses at different disease stages in patients with genital herpes simplex virus-2 infection.

Authors:  R Singh; A Kumar; W D Creery; M Ruben; A Giulivi; F Diaz-Mitoma
Journal:  Clin Exp Immunol       Date:  2003-07       Impact factor: 4.330

5.  Effectiveness of Saccharomyces boulardii in a rat model of colitis.

Authors:  Mujde Soyturk; Saba Mukaddes Saygili; Huseyin Baskin; Ozgul Sagol; Osman Yilmaz; Fatih Saygili; Hale Akpinar
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

6.  Herpes simplex virus and varicella zoster virus, the house guests who never leave.

Authors:  Paul R Kinchington; Anthony J St Leger; Jean-Marc G Guedon; Robert L Hendricks
Journal:  Herpesviridae       Date:  2012-06-12

Review 7.  Macrophages and cytokines in the early defence against herpes simplex virus.

Authors:  Svend Ellermann-Eriksen
Journal:  Virol J       Date:  2005-08-03       Impact factor: 4.099

Review 8.  Immunoregulatory Functions of Interferons During Genital HSV-2 Infection.

Authors:  Emily Feng; Elizabeth Balint; Fatemah Vahedi; Ali A Ashkar
Journal:  Front Immunol       Date:  2021-08-18       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.